Related Experiment Video
Updated: May 15, 2026

Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation
Published on: May 16, 2016
Modulating the innate immune response by combinatorial engineering of endotoxin
Brittany D Needham1, Sean M Carroll, David K Giles
1Institute of Cellular and Molecular Biology, The University of Texas at Austin, Austin, TX 78712, USA.
Researchers engineered lipid A variants to create novel immune-stimulating molecules. These engineered lipid A molecules show promise as effective adjuvants for vaccines and therapeutics, enhancing immune responses.
Area of Science:
- Immunology
- Biochemistry
- Vaccine Development
Background:
- Lipid A, the anchor of lipopolysaccharide (LPS), is a potent ligand for Toll-like receptor 4 (TLR4).
- Monophosphorylated lipid A (MPL) is an FDA-approved adjuvant, demonstrating therapeutic potential despite LPS's inflammatory nature.
- Different lipid A structures trigger distinct TLR4-mediated signaling pathways (MyD88 vs. TRIF), influencing inflammatory responses.
Purpose of the Study:
- To develop a system for combinatorial structural diversification of Escherichia coli lipid A.
- To generate a spectrum of bioactive lipid A variants with distinct TLR4 agonist activities and cytokine induction profiles.
- To evaluate the efficacy of engineered lipid A variants as adjuvants in vaccine development.
Main Methods:
- Combinatorial engineering of E. coli lipid A structures.
- Characterization of TLR4 agonist activities and cytokine induction profiles of engineered variants.
- Immunization of mice with engineered lipid A/antigen emulsions and assessment of IgG titers.
Main Results:
- A library of bioactive lipid A variants with diverse TLR4 agonist activities was successfully generated.
- Engineered lipid A variants induced distinct cytokine profiles.
- Mice immunized with engineered lipid A/antigen emulsions showed robust IgG titers, confirming adjuvant efficacy.
Conclusions:
- Combinatorial engineering of lipid A is a viable strategy to create a range of immunostimulatory molecules.
- These engineered lipid A variants hold significant potential for the development of novel vaccines and therapeutics.
- The study highlights the ability to tailor immune responses by modifying lipid A structures.
Related Concept Videos
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Transduction
Bacterial Toxins
Regulation of Bacterial Virulence
Gene Regulation in Microbial Communities: Quorum Sensing
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...

